|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: WASATCH PHARMACEUTICAL INC, 10QSB, EX-27, 2000-08-14 |
Next: TRUE NORTH COMMUNICATIONS INC, 10-Q, 2000-08-14 |
<TABLE>
<CAPTION>
------------------------------------------------------------
Three Month Period Ended June 30, 2000
------------------------------------------------------------
Date Number of Discount / Proceeds or
Recorded Shares Commission Consideration
------------------------------------------------------------
Shares Issued for Compensation and Services
<S> <C> <C> <C> <C>
Attorneys and Consultants See Pg. 2 306,056 n/a $ 382
Shares Sold to Investment Groups in
a Private Placement
ProVision Capital Funding See Pg. 2 311,582 148,430 148,432
European Equity & Guaranty Corp. See Pg. 3 14,000 11,523 12,251
Shares Issued to Pharmacy Venture Partners See Pg. 3 100,000 n/a 100
To compensate an officer for unsecured
loan to the Company See Pg. 3 110,000 n/a 220
Shares Issued to Replace Debt See Pg. 3 25,000 n/a 52,378
Exercised Stock Options See Pg. 3 3,025,000 n/a 6,550
Shares Issued As Collateral for Indebtedness See Pg. 3 2,000,000 n/a 2,000
Collateral Shares Cancelled (2,000,000) n/a (2,000)
Adjustment for fractional shares in exchange 132 n/a -
--------- --------
Increase (Decrease) in Issued Shares & Amount 3,891,770 $159,953 220,314
=========
Shares & Amount Outstanding at MARCH 31, 2000 12,141,744(A) 2,369,052(B)
---------- ----------
Shares & Amount Outstanding at End of Period 16,033,514 $2,589,366
========== ==========
Effective as of June 22, 2000, the Company exchanged one share of its common
stock for each two shares outstanding at that time.
<CAPTION>
Recapitulation of shares exchanged one for two on June 22, 2000
<S> <C>
Shares issued and outstanding per transfer agent 36,270,615
Add (Deduct)
Shares issued in trust for EEG commitment (963,677)
------------------
Shares subject to exchange 35,306,938
==================
Shares outstanding after exchange on 1for 2 basis 17,653,468
Additional shares to compensate for fractions 132
------------------
Shares outstanding after Exchange 17,653,600
New shares issued prior to June 30 379,914
------------------
Shares outstanding per the financial statements - June 30, 2000 18,033,514
==================
</TABLE>
(A) The 3/31/00 balance was decreased 5,022 shares to give effect to the
Wellrich cancellation.
(B) This balance was decreased $375.00 to give effect to change in collateral
shares held before and after the split.
1
<PAGE>
<TABLE>
<CAPTION>
-------------------------------------------------------------
Three Month Period Ended June 30, 2000
-------------------------------------------------------------
--------------------------------------------------- Date Number of Discount / Proceeds or
Certain Transaction Details Recorded Shares Commission Consideration
--------------------------------------------------- -------------------------------------------------------------
Shares Issued for Compensation and Services
Attorneys and Consultants
<S> <C> <C> <C> <C>
Lynnell Investment Trust 20-Apr-00 50,000 n/a $ 100
Howard Weitzner 20-Apr-00 10,000 n/a 20
Robert Meador 20-Apr-00 10,000 n/a 20
Kevin Leigh 20-Apr-00 1,500 n/a 3
Kevin Leigh 25-May-00 1,500 n/a 3
Precious Investments Inc. 13-Jun-00 153 n/a 0
Beverly Copeland 13-Jun-00 153 n/a 0
Brenda Greer 26-Jun-00 200,000 n/a 200
Garth Potts 27-Jun-00 30,000 n/a 30
Rose March Ator 22-Jun-00 1,250 n/a 3
Kevin Leigh 13-Jun-00 1,500 n/a 3
------- ---------
306,056 $ 382
======= =========
<CAPTION>
Shares Sold to Investment Groups in
a Private Placement
ProVision Capital Funding
<S> <C> <C> <C> <C>
Placement Nr. 5 05-Apr-00 5,002 3,685 $ 3,685
Placement Nr. 6 11-Apr-00 12,745 7,570 7,570
Placement Nr. 7 19-Apr-00 19,071 8,670 8,672
Placement Nr. 8 25-Apr-00 20,100 8,643 8,643
Placement Nr. 9 03-May-00 90,502 48,066 48,066
Placement Nr. 10 05-May-00 76,522 42,890 42,890
Placement Nr. 11 31-May-00 37,728 11,235 11,235
Placement Nr. 12 23-Jun-00 41,413 14,696 14,696
Placement Nr. 13 28-Jun-00 8,500 2,975 2,975
------- -------- --------
311,582 $148,430 $148,432
======= ======== ========
</TABLE>
2
<PAGE>
<TABLE>
<CAPTION>
-------------------------------------------------------------
Three Month Period Ended June 30, 2000
-------------------------------------------------------------
--------------------------------------------------- Date Number of Discount / Proceeds or
Certain Transaction Details Recorded Shares Commission Consideration
--------------------------------------------------- -------------------------------------------------------------
<S> <C> <C> <C> <C>
Shares Sold to Investment Groups in
a Private Placement
European Equity & Guaranty Corp.
Placement Nr. 2 09-Jun-00 14,000 11,523 $ 12,251
======== ======= ========
To compensate an officer for unsecured
loan to the Company
David Giles 06-Apr-00 110,000 n/a $ 220
======== ========
Shares Issued to Replace Debt
Tim Rice 15-May-00 (B) $ 36,070
Tim Rice 20-Jun-00 25,000 n/a 16,308
-------- --------
25,000 $ 52,378
======== ========
Shares Issued to Pharmacy Venture Partners
Dean Jolley 26-Jun-00 33,334 n/a $ 33
Joel Marsden Jolley 26-Jun-00 33,333 n/a 33
Bryce Jolley 26-Jun-00 33,333 n/a 33
-------- --------
100,000 $ 100
======== ========
Exercised Stock Options
Officers & Directors
Gary Heesch 06-Apr-00 425,000 n/a $ 850
David Giles 06-Apr-00 250,000 n/a 1,000
Gary Heesch 06-Apr-00 1,000,000 n/a 2,000
David Giles 06-Apr-00 1,000,000 n/a 2,000
Robert Arbon 06-Apr-00 250,000 n/a 500
Craig Heesch 06-Apr-00 100,000 n/a 200
-------- --------
3,025,000 $ 6,550
======== ========
Shares Issued As Collateral for Indebtedness
Oxford International 15-Jun-00 2,000,000 n/a $ 2,000
-------- --------
2,000,000 $ 2,000
======== ========
</TABLE>
(A) These officers transferred shares to ProVision Capital Funding in a private
placement and the net proceeds went directly to the company. The shares were
replaced with 1.1 shares for each share transferred.
(B) Recorded as fee in 1999 - 50,000 shares
3
|
|